DOJ Announces Opioid Fraud and Abuse Detection Unit, Followed by Large Drug Diversion Case

On August 2, 2017, Attorney General Jeff Sessions announced the formation of an Opioid Fraud and Abuse Detection Unit as a new Department of Justice (DOJ) pilot program to “utilize data to help combat the devastating opioid crisis that is ravaging families and communities across America.” The new unit will focus on identifying and prosecuting people who contribute to the nation’s prescription opioid fraud and abuse epidemic.

Read More

National Health Care Fraud Takedown

The Office of Inspector General (OIG), Department of Justice (DOJ), Federal Bureau of Investigations (FBI), and other law enforcement partners announced a National Health Care Fraud takedown. This operation marks both the largest number of healthcare fraud defendants (412) and medical professionals charged (115). The loss amount to fraud is approximately $1.3 billion. The takedown specifically targeted the opioid epidemic, including 120 individuals charged in cases involving illegal distribut...

Read More

Texas diagnostic firms, Polish company settle fraud charges for over $13.4M

Polish biotech firm Medicalgorithmics, three Texas-based diagnostic testing firms and one executive, Joseph Bogdan, of Fairview, Texas, agreed to a settlement of more than $13.4 million plus interest to resolve accusations that they violated the False Claims Act by submitting fraudulent claims to Medicare for overly expensive cardiac monitoring services, prosecutors say. AMI Monitoring and its affiliate Spectocor, based in McKinney, Texas, and Medi-Lynx Cardiac Monitoring in Plano, Texas, all...

Read More